TY - JOUR
T1 - Conversion of big endothelin isopeptides to mature endothelin isopeptides by cultured bovine endothelial cells
AU - Ohnaka, K.
AU - Takayanagi, R.
AU - Ohashi, M.
AU - Nawata, H.
PY - 1991
Y1 - 1991
N2 - Both the soluble and membrane fractions prepared from cultured bovine endothelial cells (ECs) possessed the converting activities to metabolize big endothelin-1 (big ET-1) to endothelin-1 (ET-1) at neutral pH. Metal chelators inhibited the activities of both fractions, whereas phosphoramidon, a metalloprotease inhibitor, strongly inhibited only the activity of the membrane fraction. Phosphoramidon reduced the secretion of ET-1 and concomitantly enhanced the release of big ET-1 from cultured ECs. The incubations of big ET-1, big ET-2, and big ET-3 with cultured ECs resulted in their conversions to mature ETs. Phosphoramidon also abolished these conversions. These results indicate that vascular endothelium can convert not only endogenous big ET-1 but also exogenous big ET isopeptides to their mature ETs through a phosphoramidon-sensitive neutral metalloprotease.
AB - Both the soluble and membrane fractions prepared from cultured bovine endothelial cells (ECs) possessed the converting activities to metabolize big endothelin-1 (big ET-1) to endothelin-1 (ET-1) at neutral pH. Metal chelators inhibited the activities of both fractions, whereas phosphoramidon, a metalloprotease inhibitor, strongly inhibited only the activity of the membrane fraction. Phosphoramidon reduced the secretion of ET-1 and concomitantly enhanced the release of big ET-1 from cultured ECs. The incubations of big ET-1, big ET-2, and big ET-3 with cultured ECs resulted in their conversions to mature ETs. Phosphoramidon also abolished these conversions. These results indicate that vascular endothelium can convert not only endogenous big ET-1 but also exogenous big ET isopeptides to their mature ETs through a phosphoramidon-sensitive neutral metalloprotease.
UR - http://www.scopus.com/inward/record.url?scp=0026332986&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026332986&partnerID=8YFLogxK
U2 - 10.1097/00005344-199100177-00006
DO - 10.1097/00005344-199100177-00006
M3 - Article
C2 - 1725321
AN - SCOPUS:0026332986
SN - 0160-2446
VL - 17
SP - S17-S19
JO - Journal of Cardiovascular Pharmacology
JF - Journal of Cardiovascular Pharmacology
ER -